A pathway leading to activation of BRCA1 Approximately 50% of women with a strong family history of breast cancer have a defective BRCA1 gene. The protein encoded by BRCA1 helps repair damaged DNA, but little is known about how BRCA1 is activated. It seems that the FANCD2 protein becomes monoubiquitinated in response to DNA damage. The ubiquitination serves as a targeting signal that enables FANCD2 to interact with BRCA1. Once bound, the two proteins co-operate in DNA repair.
D'Andrea believes that it may be possible to design a drug that amplifies the effects of FANCD2, thus accelerating the repair work of BRCA1 and reducing the chances that breast cancer will occur in people with a genetic predisposition for it. But, says D'Andrea, "Much work remains to be done before such therapies become a reality."
